CryoPort Story

<div class='circular--portrait' style='background:#3b5998;color: #F0F8FF;font-size:4em;'>CR</div>
CYRX -- USA Stock  

USD 45.53  0.13  0.28%

CryoPort Current Ratio is fairly stable at the moment as compared to the past year. CryoPort reported Current Ratio of 18.86 in 2019. Debt to Equity Ratio is likely to rise to 0.08 in 2020, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.9 M) in 2020. The essential goal of this article is to break down our current position on CryoPort for investors considering to short it. We will inspect why CryoPort investors may still consider a stake in the business.
Published over a month ago
View all stories for CryoPort | View All Stories
Are CryoPort (NASDAQ:CYRX) investors starting to hold back?
The company has a beta of -0.3398. Let's try to break down what CryoPort's beta means in this case. CryoPort returns are very sensitive to returns on the market. As the market goes up or down, CryoPort is expected to follow. The beta indicator helps investors understand whether CryoPort moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if CryoPort deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as CryoPort. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for CryoPort


How important is CryoPort's Liquidity

CryoPort financial leverage refers to using borrowed capital as a funding source to finance CryoPort ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. CryoPort financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between CryoPort's total debt and its cash.

How CryoPort utilizes its cash?

To perform a cash flow analysis of CryoPort, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash CryoPort is receiving and how much cash it distributes out in a given period. The CryoPort cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. CryoPort Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. CryoPort reported Net Cash Flow from Operations of (1.32 Million) in 2019

Sale by Edward Zecchini of 8334 shares of CryoPort

Legal trades by CryoPort insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
CryoPort insider trading alert for sale of common stock by Edward Zecchini, the corporate stakeholder, on 23rd of August 2020. This event was filed by Cryoport Inc with SEC on 2020-05-14. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Going after CryoPort Financials

The current price rise of CryoPort could raise concerns from investors as the firm closed today at a share price of 35.24 on 1,806,372 in volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in September. The stock standard deviation of daily returns for 30 days investing horizon is currently 3.18. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from CryoPort partners.

Margin Breakdown

EBITDA Margin(0.46)
Gross Margin0.55
Profit Margin(0.58)

Are CryoPort technical ratios showing a throwback?

Downside deviation is down to 2.69. It may suggest a possible volatility slide. CryoPort currently demonstrates below-verage downside deviation. It has Information Ratio of 0.26 and Jensen Alpha of 1.04. However, we do advice investors to further question CryoPort expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.

Our Conclusion on CryoPort

While some other companies under the integrated freight & logistics industry are still a bit expensive, CryoPort may offer a potential longer-term growth to investors. To sum up, as of the 23rd of August 2020, our analysis shows that CryoPort almost neglects market trends. The company is overvalued and projects quite high chance of bankruptcy for the next 2 years. Our final 30 days buy-or-sell advice on the company is Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of CryoPort. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com